Non-coding RNAs: More Questions than Answers
暂无分享,去创建一个
[1] J. Chang,et al. Recent advances in anti-survivin treatments for cancer. , 2010, Current medicinal chemistry.
[2] M. Gerstein,et al. What is a gene, post-ENCODE? History and updated definition. , 2007, Genome research.
[3] R. Kanwar,et al. Foundation review : Antiangiogenic therapy using nanotechnological-based delivery system , 2011 .
[4] C. Hamm,et al. The impact of epigenomics on future drug design and new therapies. , 2011, Drug discovery today.
[5] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[6] Forrest M Kievit,et al. Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers , 2011, Advanced materials.
[7] Howard Y. Chang,et al. Long intergenic noncoding RNAs: new links in cancer progression. , 2011, Cancer research.
[8] G. Krissansen,et al. ‘Iron‐saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy , 2008, Immunology and cell biology.
[9] J. Mattick,et al. Non-coding RNA. , 2006, Human molecular genetics.
[10] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[11] Chunxiang Zhang. Novel functions for small RNA molecules. , 2009, Current opinion in molecular therapeutics.
[12] F. Costa,et al. Non‐coding RNAs: Meet thy masters , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[14] F. Costa,et al. Non-coding RNAs, epigenetics and complexity. , 2008, Gene.
[15] Paulo P. Amaral,et al. The Eukaryotic Genome as an RNA Machine , 2008, Science.
[16] M. Soares,et al. Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma , 2011, PloS one.
[17] R. Kanwar,et al. Targeting survivin in cancer: the cell-signalling perspective. , 2011, Drug discovery today.
[18] Pamela K. Kreeger,et al. Cancer systems biology: a network modeling perspective , 2009, Carcinogenesis.
[19] Fabricio F Costa,et al. Cancer Management and Research Dovepress Epigenomics in Cancer Management , 2022 .
[20] R. Kanwar,et al. Targeting survivin in cancer: patent review , 2010, Expert opinion on therapeutic patents.
[21] R. Kanwar,et al. Survivin Signaling in Clinical Oncology: A Multifaceted Dragon , 2013, Medicinal research reviews.
[22] A. Feinberg,et al. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA , 2008, Nature.
[23] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[24] E. Lander. Initial impact of the sequencing of the human genome , 2011, Nature.
[25] R. Kanwar,et al. Chimeric aptamers in cancer cell-targeted drug delivery , 2011, Critical reviews in biochemistry and molecular biology.
[26] R. Kanwar,et al. Cancer Targeted Nanoparticles Specifically Induce Apoptosis in Cancer Cells and Spare Normal Cells , 2012 .
[27] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[28] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[29] K. Morris. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells , 2009, Epigenetics.